Activation of the TLR4-myD88-NFκB signaling pathway, an important pathway associated with hepatic fibrosis and HCC, can lead to the release of downstream inflammatory factors and induce the production of IL-1, IL-6, and TNF-α. The gene discussed is IL6; the disease is hepatocellular carcinoma.